Israel Englander Theravance Biopharma, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q2 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 43,807 shares of TBPH stock, worth $609,793. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,807

Previous 291,534 84.97%

Holding current value

$609,793

Previous $2.6 Million 81.44%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$8.32 - $11.25 $2.06 Million - $2.79 Million	-247,727 Reduced 84.97%	43,807 $483,000
Q1 2025 May 15, 2025	BUY	$8.44 - $10.47 $832,985 - $1.03 Million	98,695 Added 51.18%	291,534 $2.6 Million
Q4 2024 Feb 14, 2025	BUY	$7.93 - $10.08 $635,510 - $807,811	80,140 Added 71.11%	192,839 $1.81 Million
Q3 2024 Nov 14, 2024	BUY	$7.66 - $10.25 $386,293 - $516,907	50,430 Added 80.99%	112,699 $908,000
Q2 2024 Aug 14, 2024	BUY	$8.29 - $9.92 $18,644 - $22,310	2,249 Added 3.75%	62,269 $528,000
Q1 2024 May 15, 2024	SELL	$8.22 - $11.59 $494,391 - $697,080	-60,145 Reduced 50.05%	60,020 $538,000
Q4 2023 Feb 14, 2024	BUY	$8.58 - $11.4 $878,557 - $1.17 Million	102,396 Added 576.26%	120,165 $1.35 Million
Q2 2023 Aug 14, 2023	SELL	$10.16 - $11.92 $1.24 Million - $1.45 Million	-121,937 Reduced 87.28%	17,769 $183,000
Q1 2023 May 15, 2023	SELL	$9.87 - $11.44 $5.29 Million - $6.13 Million	-535,784 Reduced 79.32%	139,706 $1.52 Million
Q4 2022 Feb 14, 2023	BUY	$9.65 - $11.34 $240,593 - $282,728	24,932 Added 3.83%	675,490 $7.58 Million
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $5.46 Million - $6.65 Million	650,558 New	650,558 $6.6 Million
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $149,740 - $184,103	-17,805 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.33 - $12.96 $47,381 - $73,716	-5,688 Reduced 24.21%	17,805 $170,000
Q4 2021 Feb 14, 2022	SELL	$7.42 - $11.05 $6.84 Million - $10.2 Million	-922,041 Reduced 97.52%	23,493 $260,000
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $5.38 Million - $11.5 Million	794,983 Added 528.05%	945,534 $7 Million
Q2 2021 Aug 16, 2021	BUY	$14.52 - $22.46 $460,022 - $711,577	31,682 Added 26.65%	150,551 $2.19 Million
Q1 2021 May 17, 2021	BUY	$16.57 - $21.08 $1.57 Million - $1.99 Million	94,617 Added 390.14%	118,869 $2.43 Million
Q4 2020 Feb 16, 2021	BUY	$14.89 - $20.16 $112,925 - $152,893	7,584 Added 45.5%	24,252 $431,000
Q3 2020 Nov 16, 2020	BUY	$14.79 - $22.49 $246,519 - $374,863	16,668 New	16,668 $246,000
Q1 2020 May 14, 2020	SELL	$17.84 - $31.21 $1.79 Million - $3.14 Million	-100,551 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.12 - $25.89 $1.62 Million - $2.6 Million	100,551 New	100,551 $2.6 Million
Q2 2019 Aug 14, 2019	SELL	$15.6 - $25.15 $259,318 - $418,068	-16,623 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$22.57 - $28.15 $375,181 - $467,937	16,623 New	16,623 $377,000
Q4 2018 Feb 14, 2019	SELL	$22.52 - $35.07 $2.96 Million - $4.62 Million	-131,596 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$22.83 - $32.67 $2.02 Million - $2.89 Million	88,430 Added 204.86%	131,596 $4.3 Million
Q2 2018 Aug 14, 2018	SELL	$22.06 - $25.52 $528,513 - $611,408	-23,958 Reduced 35.69%	43,166 $979,000
Q1 2018 May 15, 2018	BUY	$23.37 - $29.71 $1.22 Million - $1.55 Million	52,086 Added 346.36%	67,124 $1.63 Million
Q4 2017 Feb 14, 2018	BUY	$25.82 - $35.66 $388,281 - $536,255	15,038	15,038 $419,000

Others Institutions Holding TBPH

# of Institutions

138

Shares Held

48.1M

Call Options Held

Put Options Held

11.6K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $930M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account